Davis, CA. – March 07, 2016 – Mytrus, a pioneer in innovative technologies for improving patients’ participation in clinical trials, has announced that its AdaptableEnroll® and Engage™ technology infrastructure will support the ADAPTABLE (Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness) trial being conducted by the Duke Clinical Research Institute (DCRI) as the study’s academic coordinating center.

ADAPTABLE will enroll 20,000 patients—drawn from multiple large healthcare systems – and is designed to compare the effects of two different daily doses of aspirin for patients diagnosed with established atherosclerotic cardiovascular disease. The enrollment process will be supported by Enroll®, Mytrus’ application for educating potential clinical trial participants and remotely gaining their electronic consent for trial participation. Then, Mytrus’ Engage™ virtual trial platform will be used to randomize patients through an interactive web portal, follow them throughout the 30-month study, and provide a platform for investigators and clinical staff to interact with patients and collect patient-reported outcomes using web-based technologies.
Read more about: